tiprankstipranks
Trending News
More News >
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market

VistaGen Therapeutics (VTGN) Technical Analysis

Compare
833 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
VistaGen Therapeutics’s (VTGN) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting VistaGen Therapeutics is a Buy.
VistaGen Therapeutics’s (VTGN) 20-Day exponential moving average is 2.34, while VistaGen Therapeutics’s (VTGN) share price is $2.06, making it a Sell.
VistaGen Therapeutics’s (VTGN) 50-Day exponential moving average is 2.38, while VistaGen Therapeutics’s (VTGN) share price is $2.06, making it a Sell.

VistaGen Therapeutics (VTGN) Pivot Points

Jun 20, 2025, 08:34 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.13
2.21
2.29
2.37
2.45
2.53
2.61
Fibonacci
2.21
2.27
2.31
2.37
2.43
2.47
2.53
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

VistaGen Therapeutics (VTGN) Moving Averages

Jun 20, 2025, 08:34 AM
Period
Simple
Exponential
MA5
2.27Sell
2.25Sell
MA10
2.32Sell
2.30Sell
MA20
2.39Sell
2.34Sell
MA50
2.30Sell
2.38Sell
MA100
2.51Sell
2.50Sell
MA200
2.71Sell
2.74Sell
VistaGen Therapeutics’s (VTGN) 10-Day exponential moving average is 2.30, while VistaGen Therapeutics’s (VTGN) share price is $2.06, making it a Sell.
VistaGen Therapeutics’s (VTGN) 100-Day exponential moving average is 2.50, while VistaGen Therapeutics’s (VTGN) share price is $2.06, making it a Sell.
VistaGen Therapeutics’s (VTGN) stock price is $2.06 and VistaGen Therapeutics’s (VTGN) 50-day simple moving average is 2.30, creating a Sell signal.
VistaGen Therapeutics’s (VTGN) stock price is $2.06 and VistaGen Therapeutics’s (VTGN) 100-day simple moving average is 2.51, creating a Sell signal.
VistaGen Therapeutics’s (VTGN) stock price is $2.06 and VistaGen Therapeutics’s (VTGN) 200-day simple moving average is 2.71, creating a Sell signal.

VistaGen Therapeutics (VTGN) Technical Indicators

Jun 20, 2025, 08:34 AM
Name
Value
Implied Action
RSI (14)
35.76
Neutral
STOCH (9,6)
40.58
Neutral
STOCHRSI (14)
28.78
Neutral
MACD (12,26)
-0.03
Buy
ADX (14)
12.93
Buy
Williams %R
-98.11
Buy
CCI (14)
-233.10
Buy
ATR (14)
0.16
-
Ultimate Oscillator
42.07
Neutral
ROC
-19.22
Sell
VistaGen Therapeutics’s (VTGN) Relative Strength Index (RSI) is 35.76, creating a Neutral signal.
VistaGen Therapeutics’s (VTGN) Trend Strength Indicator (ADX) is 12.93, creating a Buy signal.
VistaGen Therapeutics’s (VTGN) Commodity Channel Index (CCI) is -233.10, creating a Buy signal.
VistaGen Therapeutics’s (VTGN) Price Rate of Change (ROC) is -19.22, creating a Sell signal.

FAQ

Is VTGN a Buy, Hold, or Sell?
Based on VTGN’s technical indicators, VTGN is a Sell.
    What is VTGN’s RSI (14)?
    VTGN’s RSI (14) is 35.76, which suggests VTGN is a Neutral.
      What is VTGN’s MACD?
      VTGN’s MACD is -0.03, which suggests VTGN is a Buy.
        What is VTGN’s 5-day moving average?
        VTGN’s 5-day moving average is 2.27, which suggests VTGN is a Sell.
          What is VTGN’s 20-day moving average?
          VTGN 20-day moving average is 2.39, which suggests VTGN is a Sell.
            What is VTGN’s 50-day moving average?
            VTGN’s 50-day moving average is 2.30, which suggests VTGN is a Sell.
              What is VTGN’s 200-day moving average?
              VTGN’s 200-day moving average is 2.71, which suggests VTGN is a Sell.
                What is VTGN’s Williams % R (14)?
                VTGN’s Williams % R (14) is -98.11, which suggests VTGN is a Buy.
                  What is VTGN’s CCI (14)?
                  VTGN’s CCI (14) is -233.10, which suggests VTGN is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis